Frontelo P - Search Results

1

Urokinase expression and binding activity associated with the transforming growth factor beta1-induced migratory and invasive phenotype of mouse epidermal keratinocytes.

Santibáñez JF, Frontelo P, Iglesias M, Martínez J, Quintanilla M. Santibáñez JF, et al. Among authors: frontelo p. J Cell Biochem. 1999 Jul 1;74(1):61-73. J Cell Biochem. 1999. PMID: 10381262

2

Chronic exposure of cultured transformed mouse epidermal cells to transforming growth factor-beta 1 induces an epithelial-mesenchymal transdifferentiation and a spindle tumoral phenotype.

Caulín C, Scholl FG, Frontelo P, Gamallo C, Quintanilla M. Caulín C, et al. Among authors: frontelo p. Cell Growth Differ. 1995 Aug;6(8):1027-35. Cell Growth Differ. 1995. PMID: 8547217

3

Involvement of the Ras/MAPK signaling pathway in the modulation of urokinase production and cellular invasiveness by transforming growth factor-beta(1) in transformed keratinocytes.

Santibáñez JF, Iglesias M, Frontelo P, Martínez J, Quintanilla M. Santibáñez JF, et al. Among authors: frontelo p. Biochem Biophys Res Commun. 2000 Jul 5;273(2):521-7. doi: 10.1006/bbrc.2000.2946. Biochem Biophys Res Commun. 2000. PMID: 10873638

4

Blockade of Smad4 in transformed keratinocytes containing a Ras oncogene leads to hyperactivation of the Ras-dependent Erk signalling pathway associated with progression to undifferentiated carcinomas.

Iglesias M, Frontelo P, Gamallo C, Quintanilla M. Iglesias M, et al. Among authors: frontelo p. Oncogene. 2000 Aug 24;19(36):4134-45. doi: 10.1038/sj.onc.1203764. Oncogene. 2000. PMID: 10962574 Free article.

5

Transforming growth factor beta 1 induces squamous carcinoma cell variants with increased metastatic abilities and a disorganized cytoskeleton.

Frontelo P, González-Garrigues M, Vilaró S, Gamallo C, Fabra A, Quintanilla M. Frontelo P, et al. Exp Cell Res. 1998 Nov 1;244(2):420-32. doi: 10.1006/excr.1998.4219. Exp Cell Res. 1998. PMID: 9806792

6

Suv39h histone methyltransferases interact with Smads and cooperate in BMP-induced repression.

Frontelo P, Leader JE, Yoo N, Potocki AC, Crawford M, Kulik M, Lechleider RJ. Frontelo P, et al. Oncogene. 2004 Jul 1;23(30):5242-51. doi: 10.1038/sj.onc.1207660. Oncogene. 2004. PMID: 15107829

7

A retrospective pooled analysis of trabectedin safety in 1,132 patients with solid tumors treated in phase II clinical trials.

Le Cesne A, Yovine A, Blay JY, Delaloge S, Maki RG, Misset JL, Frontelo P, Nieto A, Jiao JJ, Demetri GD. Le Cesne A, et al. Among authors: frontelo p. Invest New Drugs. 2012 Jun;30(3):1193-202. doi: 10.1007/s10637-011-9662-0. Epub 2011 Apr 12. Invest New Drugs. 2012. PMID: 21484250 Clinical Trial.

8

Novel role for EKLF in megakaryocyte lineage commitment.

Frontelo P, Manwani D, Galdass M, Karsunky H, Lohmann F, Gallagher PG, Bieker JJ. Frontelo P, et al. Blood. 2007 Dec 1;110(12):3871-80. doi: 10.1182/blood-2007-03-082065. Epub 2007 Aug 22. Blood. 2007. PMID: 17715392 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters